| DGOCX | VSTSX | DGOCX / VSTSX | |
| Total Expense Ratio | 1.75 | 0.01 | 17,500% |
| Annual Report Gross Expense Ratio | 1.76 | 0.01 | 17,600% |
| Fund Existence | 28 years | 10 years | - |
| Gain YTD | 3.962 | 1.382 | 287% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 617M | 2.06T | 0% |
| Annual Yield % from dividends | 0.03 | 1.12 | 2% |
| Returns for 1 year | -0.85 | 14.81 | -6% |
| Returns for 3 years | -2.93 | 64.11 | -5% |
| Returns for 5 years | -14.04 | 68.33 | -21% |
| Returns for 10 years | 21.38 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSL | 110.66 | 0.59 | +0.54% |
| Invesco DW Consumer Staples Momt ETF | |||
| GNMA | 44.56 | N/A | N/A |
| iShares GNMA Bond ETF | |||
| IBRN | 32.98 | N/A | N/A |
| iShares Neuroscience and Healthcare ETF | |||
| FELV | 36.30 | -0.01 | -0.04% |
| Fidelity Enhanced Large Cap Value ETF | |||
| TCAL | 23.64 | -0.07 | -0.30% |
| T. Rowe Price Capital Appreciation Premium Income ETF | |||